{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-035179","form_type":"8-K","ticker":"XWEL","cik":"0001410428","company_name":"XWELL, Inc.","filed_at":"2025-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.201530+00:00","generated_at":"2026-05-23T14:25:32.212288+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"confidence":"high","headline":"XWELL reports FY 2024 revenue $33.9M (+13% YoY), net loss narrows to $16.9M","bullets":["Revenue $33.9M (+13% YoY); gross margin rose to 26.3% from 12.2%.","Net loss attributable to XWELL narrowed to $16.9M from $27.7M in 2023.","CDC extended Traveler-based Genomic Surveillance Program for 3 years; base value $53.7M, ceiling $85.7M.","Closed $4M private placement in Jan 2025; plans to acquire medical spas in select metros in 2025.","Cash & equivalents $4.6M, marketable securities $7.3M, no long-term debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-035179","json":"https://secwatch.observer/filing/0001104659-25-035179.json","markdown":"https://secwatch.observer/filing/0001104659-25-035179.md","text":"https://secwatch.observer/filing/0001104659-25-035179.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410428/000110465925035179/0001104659-25-035179-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410428/000110465925035179/tm2512312d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T14:25:32.212288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}